Cns Pharmaceuticals, Inc. · NASDAQ:CNSP
Ikarian Capital, LLC reported a 9.90% stake in Cns Pharmaceuticals, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Ikarian Capital, LLC reported a 9.90% stake in Cns Pharmaceuticals, Inc., 147,290 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 147,290
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Ikarian Capital, LLC | 9.90% | 147,290 |
| Neil Shahrestani | 9.90% | 147,290 |
Source
Related
- Cns Pharmaceuticals, Inc.
- Ikarian Capital, LLC
- Cns Pharmaceuticals, Inc. shareholders
- Schedule 13G · Ikarian Capital, LLC · Apr 17, 2026
- Form 4 · Levin Rami · Aug 18, 2026
- Form 4 · Fisher Michal · Aug 18, 2026
- Form 4 · Charles Faith L. · May 20, 2026
- Schedule 13G/A · Stonepine Capital Management, LLC · May 15, 2026
- Schedule 13G/A · Stonepine Capital Management, LLC · Feb 13, 2026